SMMART Adaptive Clinical Treatment (ACT) Trial

WITHDRAWN

Identifier: CI-TRIAL-00073186
Entity page: /trial/NCT05238831 ↗
Edges: 39

Neighbours: 9 cancers15 drugs
Drawn: 24 of 24 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
SMMART Adaptive Clinical Treatment (ACT) Trial condition of …CONDITION_OFderived15 of 15
← condition of	Adult Soft Tissue Sarcoma registry condition “Recurrent Adult Soft Tissue Sarcoma” mapped CURATED_BROADER	—	—	Adult Soft Tissue Sarcoma	1	Observed	clinicaltrials	graph →
← condition of	Breast Carcinoma registry condition “Advanced Breast Carcinoma” mapped CURATED_BROADER	—	—

SMMART Adaptive Clinical Treatment (ACT) Trial intervention of …INTERVENTION_OFderived15 of 24show all (up to 200)
← intervention of	Alectinibsmall molecule registry intervention “Alectinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Alpelisibsmall molecule registry intervention “Alpelisib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Anastrozolesmall molecule registry intervention “Anastrozole” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Atezolizumabmonoclonal antibody registry intervention “Atezolizumab” (BIOLOGICAL) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Bevacizumabmonoclonal antibody registry intervention “Bevacizumab” (BIOLOGICAL) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Capecitabinesmall molecule registry intervention “Capecitabine” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Carboplatinsmall molecule registry intervention “Carboplatin” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Cobimetinibsmall molecule registry intervention “Cobimetinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Entrectinibsmall molecule registry intervention “Entrectinib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Eribulinsmall molecule registry intervention “Eribulin” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Fulvestrantsmall molecule registry intervention “Fulvestrant” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Irinotecansmall molecule registry intervention “Irinotecan” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Letrozolesmall molecule registry intervention “Letrozole” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Nab-paclitaxel registry intervention “Nab-paclitaxel” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →
← intervention of	Niraparibsmall molecule registry intervention “Niraparib” (DRUG) mapped ALIAS	—	—	not mapped	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Paths